Skip to main content
Premium Trial:

Request an Annual Quote

Celera s Chinese Subsidiary Pens SNP Deal with Macrogen of S. Korea

NEW YORK, Feb 22 - Celera’s Chinese subsidiary Shanghai GeneCore Biotechnologies and Macrogen of South Korea have penned an agreement to jointly develop a SNP database, The Korea Times said Wednesday.

Macrogen, which offers custom sequencing services and has developed DNA chips as well as a set of customized transgenic mice, is currently exploring SNP patterns in the Korean population as part of its effort to branch into personalized medicine.

“In the long-term, we are hoping to cash on our genetic SNP databases, '' The Korean Times cited Suh Jung-seon, president of Macrogen,as saying. 

A Celera spokeswoman was not immediately available to discuss the terms or the structure of the deal.

Shanghai GeneCore, a genomics service company that specializes in nucleotide synthesis, DNA sequencing, bioinformatics analysis, and mutation detection, also has genome research collaborations with more than 1,000 biotech research centers, hospitals, and pharmaceutical companies in China.

Celera Genomics and its sister company Applied Biosystems each own a 47.5 percent stake in Shanghai GeneCore. The company, which was founded in 1997 by three companies, including Applied Biosystems, has on going research collaborations with several Chinese government agencies and research institutes. Celera Genomics bought its stake in the company last January.

In addition to its relationship with Shanghai GeneCore, Celera is reported to have other partnerships in Asia. According to previous press reports, Celera is a major investor in Asia Celera Biotechnology, a joint venture with Taiwan’s President Enterprises and Ho Tung Chemical.

The Scan

Study Reveals Details of SARS-CoV-2 Spread Across Brazil

A genomic analysis in Nature Microbiology explores how SARS-CoV-2 spread into, across, and from Brazil.

New Study Highlights Utility of Mutation Testing in Anaplastic Thyroid Cancer

Genetic mutations in BRAF and RAS are associated with patient outcomes in anaplastic thyroid carcinoma, a new JCO Precision Oncology study reports.

Study Points to Increased Risk of Dangerous Blood Clots in COVID-19 Patients

An analysis in JAMA Internal Medicine finds that even mild COVID-19 increases risk of venous thromboembolism.

Y Chromosome Study Reveals Details on Timing of Human Settlement in Americas

A Y chromosome-based analysis suggests South America may have first been settled more than 18,000 years ago, according to a new PLOS One study.